Genmab reported DKK30.69B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Amarin AMRN:US USD 908.3M 64.93M
Amgen AMGN:US USD 65.12B 1.42B
Artemis Alpha ATS:LN GBP 129.48M 35.04M
AstraZeneca AZN:LN USD 94.18B 2.39B
Bayer BAYN:GR EUR 131.01B 2.22B
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Exelixis EXEL:US USD 2.96B 79.97M
Fresenius Medical Care FME:GR EUR 38.41B 2.34B
Galapagos GLPG:NA EUR 4.97B 68.02M
Genmab GEN:DC DKK 30.69B 3.21B
GlaxoSmithKline GSK:LN GBP 60.15B 167M
GN Store Nord GN:DC DKK 31.08B 1.66B
Hikma Pharmaceutical HIK:LN USD 4.75B 375M
Immunogen IMGN:US USD 358.8M 63.5M
Insmed INSM:US USD 994.82M 58.54M
Lonza Group LONN:SW CHF 17.36B 613M
Merck MRK:GR EUR 50.93B 2.22B
Novartis NOVN:VX USD 118.46B 4.45B
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Roche Holding ROG:VX 86.74B 5.58B
Seattle Genetics SGEN:US USD 3.62B 11.26M
William Demant Holding WDH:DC DKK 27.34B 2.48B